These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26141837)

  • 1. Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology.
    Zysset P; Pahr D; Engelke K; Genant HK; McClung MR; Kendler DL; Recknor C; Kinzl M; Schwiedrzik J; Museyko O; Wang A; Libanati C
    Bone; 2015 Dec; 81():122-130. PubMed ID: 26141837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab.
    Keaveny TM; McClung MR; Genant HK; Zanchetta JR; Kendler D; Brown JP; Goemaere S; Recknor C; Brandi ML; Eastell R; Kopperdahl DL; Engelke K; Fuerst T; Radcliffe HS; Libanati C
    J Bone Miner Res; 2014 Jan; 29(1):158-65. PubMed ID: 23794225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthotropic HR-pQCT-based FE models improve strength predictions for stance but not for side-way fall loading compared to isotropic QCT-based FE models of human femurs.
    Luisier B; Dall'Ara E; Pahr DH
    J Mech Behav Biomed Mater; 2014 Apr; 32():287-299. PubMed ID: 24508715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Papapoulos S; Lippuner K; Roux C; Lin CJ; Kendler DL; Lewiecki EM; Brandi ML; Czerwiński E; Franek E; Lakatos P; Mautalen C; Minisola S; Reginster JY; Jensen S; Daizadeh NS; Wang A; Gavin M; Libanati C; Wagman RB; Bone HG
    Osteoporos Int; 2015 Dec; 26(12):2773-83. PubMed ID: 26202488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis.
    Engelke K; Fuerst T; Dasic G; Davies RY; Genant HK
    Bone; 2010 Jun; 46(6):1626-32. PubMed ID: 20226286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis.
    Zebaze R; Libanati C; McClung MR; Zanchetta JR; Kendler DL; Høiseth A; Wang A; Ghasem-Zadeh A; Seeman E
    J Bone Miner Res; 2016 Oct; 31(10):1827-1834. PubMed ID: 27082709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping anisotropy improves QCT-based finite element estimation of hip strength in pooled stance and side-fall load configurations.
    Panyasantisuk J; Dall'Ara E; Pretterklieber M; Pahr DH; Zysset PK
    Med Eng Phys; 2018 Sep; 59():36-42. PubMed ID: 30131112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
    Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
    Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of finite element model loading condition on fracture risk assessment in men and women: the AGES-Reykjavik study.
    Keyak JH; Sigurdsson S; Karlsdottir GS; Oskarsdottir D; Sigmarsdottir A; Kornak J; Harris TB; Sigurdsson G; Jonsson BY; Siggeirsdottir K; Eiriksdottir G; Gudnason V; Lang TF
    Bone; 2013 Nov; 57(1):18-29. PubMed ID: 23907032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male-female differences in the association between incident hip fracture and proximal femoral strength: a finite element analysis study.
    Keyak JH; Sigurdsson S; Karlsdottir G; Oskarsdottir D; Sigmarsdottir A; Zhao S; Kornak J; Harris TB; Sigurdsson G; Jonsson BY; Siggeirsdottir K; Eiriksdottir G; Gudnason V; Lang TF
    Bone; 2011 Jun; 48(6):1239-45. PubMed ID: 21419886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of stress variations in single-stance and sideways fall using image-based finite element analysis.
    Faisal TR; Luo Y
    Biomed Mater Eng; 2016 May; 27(1):1-14. PubMed ID: 27175463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis.
    Palacios S; Kalouche-Khalil L; Rizzoli R; Zapalowski C; Resch H; Adachi JD; Gallagher JC; Feldman RG; Kendler DL; Wang A; Wagman RB; Adami S
    Climacteric; 2015; 18(6):805-12. PubMed ID: 26029985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass.
    Keaveny TM; Crittenden DB; Bolognese MA; Genant HK; Engelke K; Oliveri B; Brown JP; Langdahl BL; Yan C; Grauer A; Libanati C
    J Bone Miner Res; 2017 Sep; 32(9):1956-1962. PubMed ID: 28543940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis.
    Keaveny TM; Donley DW; Hoffmann PF; Mitlak BH; Glass EV; San Martin JA
    J Bone Miner Res; 2007 Jan; 22(1):149-57. PubMed ID: 17042738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis.
    McClung MR; Boonen S; Törring O; Roux C; Rizzoli R; Bone HG; Benhamou CL; Lems WF; Minisola S; Halse J; Hoeck HC; Eastell R; Wang A; Siddhanti S; Cummings SR
    J Bone Miner Res; 2012 Jan; 27(1):211-8. PubMed ID: 21976367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finite element analyses of human vertebral bodies embedded in polymethylmethalcrylate or loaded via the hyperelastic intervertebral disc models provide equivalent predictions of experimental strength.
    Lu Y; Maquer G; Museyko O; Püschel K; Engelke K; Zysset P; Morlock M; Huber G
    J Biomech; 2014 Jul; 47(10):2512-6. PubMed ID: 24818795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
    Lewiecki EM; Keaveny TM; Kopperdahl DL; Genant HK; Engelke K; Fuerst T; Kivitz A; Davies RY; Fitzpatrick LA
    J Clin Endocrinol Metab; 2009 Jan; 94(1):171-80. PubMed ID: 18840641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography.
    Crawford RP; Cann CE; Keaveny TM
    Bone; 2003 Oct; 33(4):744-50. PubMed ID: 14555280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finite Element Analysis of Denosumab Treatment Effects on Vertebral Strength in Ovariectomized Cynomolgus Monkeys.
    Lee DC; Varela A; Kostenuik PJ; Ominsky MS; Keaveny TM
    J Bone Miner Res; 2016 Aug; 31(8):1586-95. PubMed ID: 27149403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple loading conditions analysis can improve the association between finite element bone strength estimates and proximal femur fractures: a preliminary study in elderly women.
    Falcinelli C; Schileo E; Balistreri L; Baruffaldi F; Bordini B; Viceconti M; Albisinni U; Ceccarelli F; Milandri L; Toni A; Taddei F
    Bone; 2014 Oct; 67():71-80. PubMed ID: 25014885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.